KANDICE MCALPINE: Open Payments
NPI 1437812500 · MASON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 73 payments from 17 companies in 2025. Trend: 2023 $1,301 · 2024 $3,116 · 2025 $1,641
Food & beverage: $1,641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $580 |
| Madrigal Pharmaceuticals | 5 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $169 |
| Janssen Biotech, Inc. | 5 | $114 |
| GENZYME CORPORATION | 4 | $107 |
| Ipsen Biopharmaceuticals, Inc | 5 | $101 |
| Ardelyx, Inc. | 4 | $91 |
| QOL Medical, LLC | 2 | $50 |
| Celltrion USA Inc. | 2 | $43 |
| Gilead Sciences, Inc. | 2 | $39 |
Products named: REZDIFFRA, BOTOX, SKYRIZI, ENTYVIO, TREMFYA, MAVYRET, IQIRVO, IBSRELA.
Industry payments across OH — which companies pay providers there.
